Evidence map›Paper›PMID 35504619›Full record

ArticleCell proliferation2022

GFI1 regulates chromatin state essential in human endothelial-to-haematopoietic transition.

Baoqiang Kang, Tian Zhang, Ke Huang, Tianyu Wang, Yuhang Li, Yuchan Mai, Jinbing Li, Shiying Dang, Zhishuai Zhang, Wenhao Huang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring the role of theFrontiers in genetics · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Baoqiang KangDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, China.ORCID https://orcid.org/0000-0002-6676-3022
Tian ZhangCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Ke HuangCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Tianyu WangCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.ORCID https://orcid.org/0000-0003-4169-8268
Yuhang LiCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Yuchan MaiCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Jinbing LiCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Shiying DangThe Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Zhishuai ZhangCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Wenhao HuangCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Junwei WangCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Minghui GaoCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Yi WangDepartment of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Guangjin PanCAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.ORCID https://orcid.org/0000-0002-2378-7198
Chinese Academy of Sciences · CNJilin University · CNSun Yat-sen University · CN

Funding

Department of Science and Technology of Jilin Province 20200404121YYEducation Department of Jilin Province JJKH20201122KJNational Key Research and Development Program of China, Stem Cell and Translational Research 2017YFA0102600Science and Technology Planning Project of Guangdong Province, China 2020B1212060052Strategic Priority Research Program of Chinese Academy of Sciences XDA16030504
6 · The paper itself

Abstract

objectivesDuring embryonic haematopoiesis, haematopoietic stem/progenitor cells (HSPCs) develop from hemogenic endothelial cells (HECs) though endothelial to haematopoietic transition (EHT). However, little is known about how EHT is regulated in human. Here, we report that GFI1 plays an essential role in enabling normal EHT during haematopoietic differentiation of human embryonic stem cells (hESCs).

resultsGFI1 deletion in hESCs leads to a complete EHT defect due to a closed chromatin state of hematopoietic genes in HECs. Mechanically, directly regulates important signaling pathways essential for the EHT such as PI3K signaling.etc. CONCLUTIONS: Together, our findings reveal an essential role of GFI1 mediated epigenetic mechanism underlying human EHT during hematopoiesis.

Indexed as

ChromatinHemangioblastsCell DifferentiationDNA-Binding ProteinsHematopoiesisHumansPhosphatidylinositol 3-KinasesTranscription FactorsChromatinDNA-Binding ProteinsGFI1 protein, humanPhosphatidylinositol 3-KinasesTranscription Factors

Identifiers

PMID35504619
PMCPMC9136496
OpenAlexW4225376185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.